Evidence map›Paper›PMID 32316657›Full record

ReviewMolecules (Basel, Switzerland)2020

Use of Fluorescence In Situ Hybridization (FISH) in Diagnosis and Tailored Therapies in Solid Tumors.

Natalia Magdalena Chrzanowska, Janusz Kowalewski, Marzena Anna Lewandowska

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 3 pooled it
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 3 syntheses or guidelines pooled it, 120 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Harmonization trial ofPathologica · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. FluorescenceExperimental and therapeutic medicine · 2025
    Article
  17. Review
  18. Review
  19. Genomic medicine and personalized treatment: a narrative review.Annals of medicine and surgery (2012) · 2025
    Review
  20. NGS coverage accurately predictsFrontiers in oncology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Natalia Magdalena ChrzanowskaMolecular Oncology and Genetics Department, Innovative Medical Forum, The F. Lukaszczyk Oncology Center, 85-796 Bydgoszcz, Poland.
Janusz KowalewskiDepartment of Thoracic Surgery and Tumors, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 85-067 Torun, Poland.
Marzena Anna LewandowskaMolecular Oncology and Genetics Department, Innovative Medical Forum, The F. Lukaszczyk Oncology Center, 85-796 Bydgoszcz, Poland.ORCID 0000-0002-7360-7810
Nicolaus Copernicus University · PL

Funding

Uniwersytet Mikolaja Kopernika w Toruniu UMK CM 2018 WL103
6 · The paper itself

Abstract

Fluorescence in situ hybridization (FISH) is a standard technique used in routine diagnostics of genetic aberrations. Thanks to simple FISH procedure is possible to recognize tumor-specific abnormality. Its applications are limited to designed probe type. Gene rearrangements e.g.,

Indexed as

In Situ Hybridization, FluorescenceBiomarkers, TumorChromosome PaintingHumansImmunohistochemistryMolecular ProbesNeoplasmsPrecision MedicineReproducibility of ResultsBiomarkers, TumorMolecular ProbesALKCOL1A1-PDGFBFISHHER2personalized medicinepersonalized oncologyROS1targeted treatmentt(X,18)

Identifiers

PMID32316657
PMCPMC7221545
OpenAlexW3016584580

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.